Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer's disease-Reference-Cited by-同舟云学术

Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer's disease

Published:2014-02 Issue: Volume:73 Page:56-72
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

González-Naranjo Pedro,Pérez-Macias Natalia,Campillo Nuria E.,Pérez Concepción,Arán Vicente J.,Girón Rocio,Sánchez-Robles Eva,Martín María Isabel,Gómez-Cañas María,García-Arencibia Moisés,Fernández-Ruiz Javier,Páez Juan A.

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference71 articles.

1. Cholinergically mediated augmentation of cerebral perfusion in Alzheimer's disease and related cognitive disorders: the cholinergic-vascular hypothesis;Claassen;J. Gerontol. A Biol. Sci. Med. Sci.,2006

2. Treatment of attention deficits in neurological disorders;Coulthard;Curr. Opin. Neurol.,2006

3. An update on the pharmacology of galantamine;Villarroya;Expert Opin. Investig. Drugs,2007

4. Therapeutic approaches to Alzheimer's disease;Klafki;Brain,2006

5. Tetrahydrofurobenzofuran cymserine, a potent butyrylcholinesterase inhibitor and experimental Alzheimer drug candidate, enzyme kinetic analysis;Kamal;J. Neural Transm.,2008

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Molecular Targets and Their Ligands for the Treatment of Alzheimer Disease;Current Topics in Medicinal Chemistry;2024-08-20

2. Systematic Investigation of Dual-Target-Directed Ligands;Journal of Medicinal Chemistry;2024-06-06

3. In silico Strategy: A Promising Implement in the Development of Multitarget Drugs against Neurodegenerative Diseases;Current Topics in Medicinal Chemistry;2023-11

4. Impact of Cannabinoid Receptors in the Design of Therapeutic Agents against Human Ailments;Current Topics in Medicinal Chemistry;2023-07

5. Dual-Acting Small Molecules: Subtype-Selective Cannabinoid Receptor 2 Agonist/Butyrylcholinesterase Inhibitor Hybrids Show Neuroprotection in an Alzheimer’s Disease Mouse Model;Journal of Medicinal Chemistry;2023-04-26